{"version":"1.0","provider_name":"Haavind EN","provider_url":"https:\/\/haavind.no\/en","author_name":"Camilla","author_url":"https:\/\/haavind.no\/en\/author\/camilla\/","title":"The Haavind Pharma Report Summer 2020","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"7aJnEgI8qY\"><a href=\"https:\/\/haavind.no\/en\/pharma-report-summer-2020\/\">The Haavind Pharma Report Summer 2020<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/haavind.no\/en\/pharma-report-summer-2020\/embed\/#?secret=7aJnEgI8qY\" width=\"600\" height=\"338\" title=\"&#8220;The Haavind Pharma Report Summer 2020&#8221; &#8212; Haavind EN\" data-secret=\"7aJnEgI8qY\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2022\/06\/LinkedIn_Pharma-Report.jpg","thumbnail_width":1200,"thumbnail_height":624,"description":"Haavind\u2019s Pharma Report is a retrospective report on legal developments in Norway relevant for the pharmaceutical sector and focuses on relevant developments within regulatory affairs and intellectual property. Since 2016, we have published the report twice a year, and we are pleased once again to present some of the significant legal developments that occurred during the first half of 2020."}